
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]PsiOxus Therapeutics Ltd"
Count: 11
Selected: 0
NCT ID | Title |
---|
NCT04830592 | A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck | ||
NCT03852511 | First in Human Study of NG-350A (an Oncolytic Adenoviral Vector Which Expresses an Anti-CD40 Antibody) | ||
NCT05165433 | Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY) | ||
NCT05043714 | Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours | ||
NCT04053283 | First in Human Study With NG-641, an Oncolytic Transgene Expressing Adenoviral Vector | ||
NCT02636036 | Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors | ||
NCT02028117 | Phase I / Dose Expansion Study of Enadenotucirev in Ovarian Cancer Patients | ||
NCT02053220 | Mechanism of Action Trial of ColoAd1 | ||
NCT02028442 | Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients | ||
NCT01238107 | A Clinical Study With MT-102 in Subjects With Cancer Cachexia | ||
NCT03916510 | Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer |